SCNI

Scinai Immunotherapeutics Ltd.

Healthcare · Biotechnology

$270.54 sample

+1.36 (+0.51%) 1D

Market cap

$1.60T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-03

Alerts

8

Price$270.54 +17.62% 3M daily closessample

272.78230.02

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 05INSInsider buy: Chief Financial Officer
Sep 24INSInsider sell: Chief Executive Officer
Sep 18INSInsider sell: Director
Sep 09INSInsider buy: 10% owner
Sep 03SEC8-K filed: material event
Aug 28INSInsider sell: Director
Aug 20INSInsider buy: Director
Aug 12INSInsider sell: Chief Executive Officer

Sign up to see the real SCNI record →

Company facts

SEC EDGAR registration

Name: Scinai Immunotherapeutics Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +5sample, -100 to +100
Reporting currency: USD

Who is positioning in SCNI

sample

Insiders: 16 insider transactions over 90 days, net selling, $476.0M
Congress: 4 members traded over 90 days
Institutions · 13F: 44 funds hold $13.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$51.0B +21.1% y/y

Q4 2024Q3 2026

Inventory$30.1B +9.4% y/y

Q4 2024Q3 2026

Accounts receivable$23.3B +10.5% y/y

Q4 2024Q3 2026

Total debt$60.9B +11.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.33T +2.8% 3M
Sample peer B: $1.57T -0.2% 3M
Sample peer C: $461.5B +14.7% 3M
Sample peer D: $1.35T +5.8% 3M
Sample peer E: $436.1B -11.2% 3M